The adoption of this manufacturing process in healthcare saw a tremendous uptick in 2020.
When a device is implanted in a human body, there is always a distinct reaction of the body’s immune system, often resulting in a thick layer of scar tissue surrounding the implant. With device miniaturization and by providing a ‘biomimetic’ device encapsulation, this body reaction will be reduced.
Cost justification and lack of material compatibility continue to create hurdles, but industry stakeholders have been coming together to help drive innovation.
How to improve medical device security and the importance of security updates.
While the terms rapid prototyping, additive manufacturing, and 3-D printing are used interchangeably these days, biofabrication is setting itself apart.
Researchers are studying a new biomaterial that helps healthy cells adhere to the implant, fend off bacterial cells and thus, reduce the likelihood of the implant being rejected by the body.